In our study, biomarkers specific to neuroaxonal damage and glial activation, NfL and GFAP, were associated with greater SCD assessed via the ECog-12, but not with cognitive concerns alone. The gene discussed is GFAP; the disease is Schnyder corneal dystrophy.